Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion type Assertion NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_head.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion description "[Pharmacological targeting of these proinflammatory pathways using selective receptor antagonists, or the use of transgenic mice with perturbed cell signaling, demostrated that the activation of IL-1R type 1 and TLR4 by their respective endogenous ligands, i.e., interleukin (IL)-1b and High Mobility Group Box 1, is implicated in the precipitation and recurrence of experimentally induced seizures in rodents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_provenance.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion evidence source_evidence_literature NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_provenance.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion SIO_000772 21967368 NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_provenance.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion wasDerivedFrom befree-2016 NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_provenance.
- NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_assertion wasGeneratedBy ECO_0000203 NP928138.RAtrOlIJvQtJ4P7vNxZu3F71P_UxooDw9zYjIljVln9sM130_provenance.